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Abstract—The purpose of this study was to implement a
new lactate-edited 3D
1H magnetic resonance spectroscopic
imaging (MRSI) sequence at 3 T and demonstrate the
feasibility of using this sequence for measuring lactate in
patients with gliomas. A 3D PRESS MRSI sequence
incorporating shortened, high bandwidth 180 pulses, new
dual BASING lactate-editing pulses, high bandwidth very
selective suppression (VSS) pulses and a ﬂyback echo-planar
readout was implemented at 3 T. Over-prescription factor of
PRESS voxels was optimized using phantom to minimize
chemical shift artifacts. The lactate-edited ﬂyback sequence
was compared with lactate-edited MRSI using conventional
elliptical k-space sampling in a phantom and volunteers, and
then applied to patients with gliomas. The results demon-
strated the feasibility of detecting lactate within a short scan
time of 9.5 min in both phantoms and patients. Over-
prescription of voxels gave less chemical shift artifacts
allowing detection of lactate on the majority of the selected
volume. The normalized SNR of brain metabolites using the
ﬂyback encoding were comparable to the SNR of brain
metabolites using conventional phase encoding MRSI. The
specialized lactate-edited 3D MRSI sequence was able to
detect lactate in brain tumor patients at 3 T. The implemen-
tation of this technique means that brain lactate can be
evaluated in a routine clinical setting to study its potential as
a marker for prognosis and response to therapy.
Keywords—3D magnetic resonance spectroscopic imaging,
In vivo lactate detection, Brain tumor, Glioblastoma multi-
forme.
INTRODUCTION
Lactate is a metabolic marker that is observed in
many brain pathologies.
8,11 Neoplastic processes that
are present in tumors have low oxygen supply and
depend on non-oxidative glycolysis for energy pro-
duction.
31 This means that lactate can be considered as
an indicator of anaerobic glycolysis and reduced cel-
lular oxygenation, which is of interest for evaluating
response to radiation or other therapies. The potential
for identifying regions of metabolic stress and ischemic
area in brain means that in vivo measurements of lac-
tate are of interest in patients with a number of dif-
ferent brain pathologies. Previous studies performed at
1.5 Tesla (1.5 T) have shown that the presence of lac-
tate and lipid peaks in
1H magnetic resonance spec-
troscopic imaging (MRSI) data is associated with a
diagnosis of high-grade tumor.
15,27 Elevated signals
from lactate and lipid were associated with short sur-
vival in patients with glioblastoma multiforme (GBM)
who were evaluated either prior to surgery or radiation
treatment at 1.5 T.
2,26 In these cases, increased lactate
was interpreted as an indication of increased tumor
metabolism and growth.
1,24 The detection of lactate is
thus of interest for evaluating prognosis and response
to therapy in brain tumor patients.
1H magnetic resonance spectroscopy (MRS) of
lactate demonstrates two resonances: a doublet at
1.3 ppm from methyl protons (CH3) and a quartet at
4.1 ppm from methine protons (CH). The methyl
protons and the methine protons are weakly coupled
to each other with a J-coupling constant of 6.93 Hz.
For proton in vivo spectroscopy, the methyl doublet
has been the target for lactate detection because the
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193methine peaks are close to the water resonance and are
not usually visible because of their relatively low signal
intensity. Despite this advantage, the methyl doublet
can be difﬁcult to quantify because of lipid peaks,
which overlap in the range of 0.9–1.3 ppm. In order to
overcome this problem, a number of techniques have
been developed to measure and separate the lactate
doublet from lipid resonances.
6,7,29
One such technique is based on spectral editing
using dual band selective inversion with gradient
dephasing (BASING) pulses.
29 This technique allows
for simultaneous detection of lactate at 1.3 ppm as well
as uncoupled metabolites such as choline (Cho), crea-
tine (Cr), N-acetyl-aspartate (NAA), and lipid. Based
on J-difference editing, this technique exploits the fact
that the phase of the doublet depends on the carrier
frequency of the BASING pulse acting on the quartet
at 4.1 ppm, which is weakly coupled to the doublet.
The BASING pulse, which is a frequency selective
inversion pulse surrounded by bipolar crusher gradi-
ents on orthogonal axes, places the methine quartet
within the BASING inversion band for the ﬁrst cycle
(edit-on), while the carrier frequency of the BASING
pulse is shifted in the second cycle so that the quartet is
removed from the inversion band (edit-off).
29 As a
result, the doublet becomes in-phase in the ﬁrst cycle
and 180 out-of-phase in the second cycle relative to
uncoupled spins for echo time TE = 144 ms. Summing
the two data sets provides only uncoupled spins
including Cho, Cr, NAA, and lipid, whereas sub-
tracting them renders only lactate (Fig. 1c).
Lactate editing combined with point resolved spec-
troscopy (PRESS) localized 3D MRSI has been
applied to glioma patients at 1.5 T for non-invasive
detection of lactate and other brain metabolites.
2,15,26
These studies demonstrated the detection of lactate as
well as Cho, Cr, NAA and lipid, and suggested that
in vivo measurement of lactate as well as other
MR-derived parameters may help in diagnosis and
proper therapy selection for glioma patients. Although
the increased signal strength at higher ﬁeld is expected
to enhance the sensitivity of brain metabolites includ-
ing lactate, the detection of brain lactate using
1H
MRS based on J-difference editing at 3 Tesla (3 T)
scanner has not been reported. Several studies have
reported their unsuccessful attempts at measuring
lactate in brain tumor patients using single voxel
PRESS-localized MRS at 3 T.
12,14 The poor lactate
detection that was observed at 3 T in these studies was
due to chemical shift mis-registration artifact caused
by the limited bandwidth of refocusing pulses used for
the localization of spectroscopic data.
Several studies have investigated the signal cancel-
lation of J-coupled resonance due to the chemical shift
diﬀerence between J-coupled spin partners in PRESS
MRSI sequence in the context of lactate and
GABA.
9,10 This artifact is produced because spatially
selective RF pulses cause a relative shift in the location
of the selected volume for J-coupled resonances,
thereby leading to net signal loss when the ﬁnal signal
is contributed from different regions. Kelley et al.
10
demonstrated in phantoms that BASING pulses
incorporated into non-editing PRESS sequence
reduced the artifact for the detection of lactate methyl
resonance in single voxel and MRSI data. For our
editing scheme, this artifact may happen in the second
cycle with BASING editing off, which is basically
regular J-evolution. In the present study, we sought to
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FIGURE 1. The new BASING pulse waveform designed for
3 T (a) and its inversion proﬁle (b). Carrier frequency of the
second cycle was shifted 198 Hz from the ﬁrst cycle so that
the lactate methine quartet was placed in either the passband
or the stopband. As a result, lactate doublet is upright in one
cycle and inverted in other cycle, so that summing the two
data sets produces uncoupled resonances while subtracting
them produces lactate resonance (c).
PARK et al. 194eliminate this artifact by using higher-bandwidth RF
pulses since the spatial offset due to chemical shift
difference is inversely proportional to RF bandwidth.
In addition, we over-prescribed PRESS-localized vol-
ume and applied high bandwidth saturation pulses in
order to further minimize this artifact.
The clinical use of lactate-edited MRSI based on
J-diﬀerence editing has been limited by the requirement
of two successive acquisitions per phase encoding step
and the acquisition time which has typically been
20 min.
15 Flyback echo-planar spectroscopic imaging
has been used to allow the acquisition of MRSI data in
a shorter scan time. Cunningham et al.
3 demonstrated
the feasibility and potential of MRSI data acquisition
at 3 T with high spatial resolution and large coverage
in a short scan time with ﬂyback echo-planar readout
gradient waveforms.
The purpose of this study was to implement a
lactate-edited 3D PRESS
1H MRSI sequence at 3 T
with new high bandwidth 180 pulses, new BASING
pulses and a ﬂyback echo-planar readout gradient in
order to allow a clinically suitable scan time of 10 min
and demonstrate the feasibility of using this sequence
for the detection of brain lactate as well as Cho, Cr,
NAA, and lipid in patients. We addressed the effect of
chemical shift artifact on lactate signal with different
PRESS over-prescription (over-PRESS) factors and
compared the metabolite SNR and its ratio of the
lactate-edited MRSI data between a ﬂyback echo-pla-
nar readout gradient method and conventional MRSI
with elliptical k-space sampling. The method was then
applied to patients with gliomas in order to determine
whether it could detect lactate within lesions.
MATERIALS AND METHODS
Sequence Development and Implementation
Pulse sequence development and implementation
were performed using the GE pulse sequence devel-
opment environment (version 12x). The new 3 T dual
BASING pulses were modiﬁed from the BASING
pulses developed in our laboratory for application at
1.5 T
29 to accommodate the increased spectral range at
3 T. The new waveform, derived from the Shinnar-Le
Roux algorithm,
23 had a duration of 30 ms and peak
amplitude of 57 mG (Fig. 1a). The inversion and
transition bandwidth of the waveform were 230 and
55 Hz, respectively (Fig. 1b). The sequence was mod-
iﬁed so that the center of the BASING inversion band
was placed at water (4.7 ppm) for the ﬁrst cycle and
shifted 198 Hz for the second cycle. As a result, the
lactate methine peak (4.1 ppm) was placed within the
BASING inversion band for the ﬁrst cycle and
removed from it in the subsequent cycle (Fig. 1b). The
PRESS localization scheme incorporated shortened
(6.5 ms) and higher-bandwidth (1.5 kHz) 180 refo-
cusing pulses that were designed to minimize the effect
of chemical shift mis-registration artifact at 3 T. The
center frequency of 90 and 180 pulses was placed in
the middle of lactate methyl and methine resonances at
2.64 ppm. New high bandwidth VSS pulses were cus-
tom-designed for 3 T with an 8.8 kHz bandwidth and
2 ms duration. The resulting 3D MRSI sequence
consisted of a PRESS scheme incorporating new high
bandwidth VSS pulses, higher-bandwidth 180 pulses,
new 3 T dual BASING pulses positioned after the ﬁrst
and second 180 pulses and a ﬂyback echo-planar
readout gradient. Table 1 summarizes the various
parameters for BASING, VSS, and PRESS pulses
between the 1.5 T and the newly designed 3 T.
16,29,30
Estimation of Chemical Shift Artifacts
with Over-PRESS Factors
The eﬀect of chemical shift artifacts on the excita-
tion proﬁles of lactate methyl and methine resonances
was estimated by calculating the spatial oﬀset of each
resonance using the following equation
21:
Dx ¼
ðw   w0Þ
BWRF
  XBOX; ð1Þ
where Dx is the spatial offset of the excitation proﬁle
for a metabolite with resonance frequency w, from the
carrier frequency, w0;B W RF is the bandwidth of the
PRESS RF excitation pulse in the given direction (90
or 180); and XBOX is the width of the excited spectral
region in that direction. Using Eq. (1), we estimated
TABLE 1. Comparison of BASING, VSS, and PRESS pulse parameters between the 1.5 T and the newly implemented
3 T sequence.
BASING VSS PRESS
Peak amplitude
(mG)
Inversion BW
(Hz)
Transition BW
(Hz)
BW
(kHz)
Duration
(ms)
90 pulse BW
(Hz)
180 pulse BW
(Hz)
1.5 T 30 100 55 6.5 3 2400 933
3 T 57 230 55 8.8 2 2400 1500
BW bandwidth.
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methine resonances for 1.2, 1.5, and 1.7 over-PRESS
factors, deﬁned as the ratio of the linear dimension of
the excited volume to the prescribed volume. For
simplicity, we considered only the x–y plane and
assumed that the prescribed region is a 2D box with a
size of 80 9 80 mm.
Spectroscopic Imaging
All spectroscopic imaging data were acquired using
a 3 T Signa HDx (v12x) MR scanner (GE Healthcare,
Milwaukee, WI) and an eight-channel phased array
head coil. The spectroscopic imaging data were
acquired with PRESS volume localization with an
over-PRESS factor between 1.2 and 1.7. The over-
PRESS factor was achieved by reducing the amplitude
of the slice selection gradients. Chemical shift-selective
saturation (CHESS) pulses were used for water sup-
pression. VSS pulses of width 40 mm were placed on
all sides of the prescribed volume to deﬁne the edges of
the selected volume, and six additional graphic VSS
bands were used in order to further improve the sup-
pression of subcutaneous lipids for volunteer and
patient scan. High-order shimming was performed
prior to the MRSI data acquisition to optimize the
magnetic ﬁeld homogeneity. In order to estimate the
sensitivity proﬁle of each coil element, proton density
weighted gradient-echo (GRE) images were acquired
using the manufacture-provided parallel imaging
(ASSET) calibration sequence (TR/TE = 150/20 ms).
Chemical Shift Artifacts with Diﬀerent Over-PRESS
Factors in Phantom
To study the eﬀect of chemical shift artifacts for
diﬀerent over-PRESS factors and to determine an
optimal over-PRESS factor for the new sequence,
empirical data were obtained from a GE head MRS
phantom containing 5 mM lactate as well as Cho
(3 mM), Cr (10 mM), and NAA (12.5 mM).
30 3D
MRSI data were acquired with the excited volume of
80 9 80 9 40 mm
3 using over-PRESS factors of 1.2,
1.5, and 1.7 and VSS pulses around the prescribed
volume (TR/TE = 1104/144 ms, FOV = 16 9 16 9
16 cm, voxel size = 1 9 1 9 1 cm, ﬂyback echo-
planar readout gradient in SI direction, 712 dwell
points, 988 Hz bandwidth). In order to evaluate the
variation in lactate signal across the excited volume for
different over-PRESS factors, the mean value of lac-
tate SNR was calculated from the right, left, middle,
anterior, and posterior of the central two slices
(Fig. 2). In addition, the peak height ratio of choline to
NAA (Cho/NAA) was calculated and compared for
three over-PRESS factors.
Comparison Between the Conventional Phase Encoding
and Flyback Readout Gradient Methods
In order to compare signal quality between the con-
ventional phase encoding and ﬂyback readout gradient
methods, a phantom and two volunteers were scanned
using lactate-edited PRESS MRSI with both the con-
ventional phase encoding (TR/TE = 1104/144 ms,
FOV = 12 9 12 9 8 cm, nominal voxel size = 1 9
1 9 1 cm (1 cc), eﬀective resolution = 2.5 cc, total
acquisition time = 19 min, 1024 dwell points, and
2000 Hz bandwidth) and the ﬂyback echo-planar
readout gradient applied in SI (z) dimension (TR/
TE = 1104/144 ms, FOV = 16 9 16 9 16 cm, voxel
size = 1 9 1 9 1 cm (1 cc), total acquisition time =
9.5 min, 712 dwell points, and 988 Hz bandwidth). An
over-PRESS factor of 1.5 was chosen for both methods.
For the conventional MRSI method, an elliptical
k-space sampling was applied so that the radius of the
ellipsoid was chosen to reduce the acquisition time to
approximately one-half of that of the full rectangular
sampling.
15 The number of phase encoding steps was
reduced from 1152 (12 9 12 9 8) to 512 through zero
ﬁlling the appropriate k-space points outside a nor-
malized ellipsoidal radius of1.2.
33 TheSNRofCho, Cr,
NAA, and lactate were calculated from the middle four
voxels of the central two slices for the phantom, and the
SNR of Cho, Cr, and NAA in normal appearing white
matter (NAWM) for the volunteers. The SNR of the
ﬂyback method was normalized to compensate for dif-
ferent scan times and effective spatial resolutions between
the ﬂyback and conventional MRSI methods by:
nSNRflyback ¼SNRflyback 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
TAconventional
p
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
TAflyback
p  
DVconventional
DVflyback
;
ð2Þ
where nSNRﬂyback is the normalized SNR of ﬂyback
data, SNRﬂyback is the raw SNR of ﬂyback data, TA is
the total acquisition time, and DV is the effective spatial
PRESS 
Middle 
Posterior 
Anterior 
Left  Right 
FIGURE 2. Lactate-edited 3D PRESS MRSI was applied to
study the effect of chemical shift artifacts on lactate signal
and other brain metabolites. The mean value of lactate SNR
and choline to NAA ratio were calculated from the right, left,
middle, anterior, and posterior voxels of the central two slices.
PARK et al. 196resolution. The reduced elliptical k-space sampling in
the conventional MRSI method resulted in an increase
in the effective spatial resolution.
17,18 A recent study
has compared the effective spatial resolution between
the elliptical k-space sampling in the conventional
phase encoding method and the rectangular k-space
sampling in the ﬂyback method.
33 The authors used the
spatial response function (SRF) generated by Fourier
reconstruction in order to calculate the effective volume
for each method and reported that the effective spatial
resolutions for the conventional and ﬂyback methods
were 2.473 and 1.014 cm
3, respectively. This resulted in
an additional factor of 2.439 being required to correct
for the difference between the effective spatial resolu-
tion of the conventional and ﬂyback methods:
DVconventional ¼ 2:439 DVflyback ð3Þ
This ratio was consistent with the previous ﬁnding,
obtained by comparing the SNR of NAA in NAWM
between the two methods.
22 Considering both the
effective spatial resolution and differences in scan time
between the conventional and ﬂyback methods, a fac-
tor of 3.4 was used to normalize the SNR of the ﬂy-
back method.
nSNRflyback ¼ 3:4   SNRflyback ð4Þ
Patient Data Acquisition
A total of 10 patients (eight male, two female, med-
ian age 55, range 41–64) with GBM were included in
this study. Some patients had more than one exami-
nation and a total of 34 scans from these patients were
examined to demonstrate the feasibility of using the
new lactate-edited 3D MRSI sequence for the detection
of lactate in brain tumor at 3 T. All patients were
scanned using 3 T lactate-edited PRESS 3D MRSI
sequence with the ﬂyback echo-planar readout gradient
applied in SI dimension using an over-PRESS factor of
1.5 (TR/TE = 1104/144 ms, FOV = 16 9 16 9 16 cm,
voxel size = 1 9 1 9 1 cm, total acquisition time =
9.5 min, 712 dwell points, and 988 Hz bandwidth). The
MRI protocol included an axial T2-weighted ﬂuid
attenuated inversion recovery (FLAIR) sequence
4
with 3-mm slice thickness and axial pre- and post-
gadolinium-DTPAT1-weightedspoiledgradientrecalled
(SPGR) images with 1.5-mm thickness. All patients
provided informed consent as approved by the com-
mittee on human research at our institution.
Data Processing and Quantiﬁcation
The method used for spectral quantiﬁcation has
been described previously.
19 In brief, the 3D MRSI
data with the conventional phase encoding were
reconstructed by processing each of the spectra from
the eight-channel coil individually, apodizing with a
4 Hz Lorentzian ﬁlter in the time domain, zero ﬁlling
to 1024 points, applying phase and frequency correc-
tion, and then removing residual water and baseline.
The individual data were Fourier-transformed to pro-
duce a 3D spatial array of spectra and combined using
in-house developed software that weights the data by
their coil sensitivities from the low resolution proton
density weighted images.
16,25 The two cycles of data
were then either summed or subtracted to produce a
3D array of summed or subtracted spectra.
The 3D MRSI data with the ﬂyback echo-planar
readout were reconstructed and combined in the same
way as the data with the conventional phase encoding,
but with the application of an additional linear phase
correction in the SI dimension of spectral k-space to
prevent spatial chemical shift artifacts.
3 To reconstruct
the data acquired with the ﬂyback echo-planar readout
gradient, only samples from the ﬂat part (plateau) of
the gradient waveforms were used.
The SNR of brain metabolites was calculated using
the previously published method.
20 The region of 100
spectral points without metabolite signal was selected
to estimate the standard deviation (SD) of the noise.
Sub-regions with a size of 20, 40, and 80 points were
made and located at the beginning of the selected
region. The location of the sub-region was incremented
by 1 point until it reached the end of the selected
region, resulting in a total of 81, 61, and 21 divisions,
respectively. For each sub-region, the SD was com-
puted, the minimum SD was taken for each division,
and the minimum SD of the divisions was used for the
ﬁnal SD of noise. The SNR of peak height over the SD
of noise was calculated for Cho, Cr, NAA, and lactate.
In order to quantify lactate level in patients, median
lactate SNR was estimated for each examination.
Lactate peaks with SNR equal to or greater than 4
were only included in calculating the median lactate
SNR. The estimation of lactate SNR was conﬁned to
the lactate appearing in contrast enhancing lesion
(CEL) or T2 hyperintense region (T2h). The lactate
found in resection cavity, necrotic region, or cerebro-
spinal ﬂuid was excluded from the analysis.
RESULTS
Estimation of Chemical Shift Artifacts
with Over-PRESS Factors
Figure 3 illustrates the effect of chemical shift mis-
registration artifact on the lactate excitation proﬁles
for 1.2 and 1.5 over-PRESS factors. Using a 96 9
96 mm excited box with an 1.2 over-PRESS factor,
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1H MRSI of Gliomas Patients at 3 T 1971500 and 2400 Hz bandwidth of the PRESS 180 (RL
direction) and 90 pulses (AP direction), respectively,
170 Hz shift of lactate methyl resonance (1.3 ppm)
from the carrier frequency (2.64 ppm), and the direc-
tionality information of the chemical shift artifact,
Eq. (1) estimated the lactate methyl excitation proﬁle
(dashed line) to be shifted from the carrier frequency
excitation proﬁle (solid line) by 11 mm in RL direction
and 6.8 mm in AP direction toward the top-left corner
and the lactate methine excitation proﬁle (dotted line)
by 12 mm in RL direction and 7.5 mm in AP direction
toward the bottom-right corner (Fig. 3a). As a result,
it produces a region with a size of 73 9 82 mm
(highlighted box) where both the lactate methyl and
methine resonances are equally excited and a portion
of the prescribed box in RL direction where only one
of the lactate resonances is excited. Similarly, using an
120 9 120 mm and 136 9 136 mm excited box with
the over-PRESS factors of 1.5 and 1.7, respectively, the
1.5 over-PRESS factor produces a 91 9 102 mm
region (Fig. 3b) and the 1.7 over-PRESS factor a
104 9 116 mm region with the simultaneous excitation
of two lactate resonances. Given the size of the pre-
scribed box (80 9 80 mm), the chemical shift artifact is
expected to be most pronounced with an 1.2 over-
PRESS factor and more accentuated in RL direction
compared to AP direction due to the lower bandwidth
of 180 pulse (1.5 kHz) used for selection in RL
direction compared to the bandwidth of 90 pulse
(2.4 kHz) used for selection in AP direction. Our
phantom data were consistent with this observation in
that the chemical shift artifact manifested as the signal
cancellation of lactate doublet was most apparent in
the left column and improved with increases in the
over-PRESS factor (Figs. 4 and 5).
The Eﬀect of Chemical Shift Artifacts on Metabolite
Signal in Phantom
As expected, the eﬀect of chemical shift artifacts on
lactate signal variation across the exited volume was
reduced as the over-PRESS factor increased. Mean
lactate SNR from the right, left, middle, anterior, and
posterior voxels are plotted against the over-PRESS
factors of 1.2, 1.5, and 1.7 in Fig. 4. The mean and SD
of lactate SNR from the ﬁve locations are summarized
in Table 2. The mean lactate SNRs were similar for
different over-PRESS factors. In contrast, the SD of
lactate SNR decreased with increases in the over-
PRESS factor, indicating that the chemical shift
mis-registration artifact lessened with increase in the
over-PRESS factor. The lactate SNR from the left
voxel showed the largest variation across the three
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FIGURE 3. The illustration of chemical shift mis-registration
artifact for 1.2 and 1.5 over-PRESS factors. The 1.2 over-
PRESS factor produces shifted excitation proﬁles for lactate
methyl (dashed line) and methine (dotted line) resonances
from the excitation proﬁle of carrier frequency (solid line),
resulting in a 73 3 82 mm region with the simultaneous
excitation of two lactate resonances (a). Similarly, the 1.5
over-PRESS factor produces a 91 3 102 mm region with the
simultaneous excitation of two lactate resonances (b) and
therefore smaller chemical shift artifacts compared to the 1.2
over-PRESS factor.
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FIGURE 4. The effect of chemical shift artifacts on brain metabolite signal was evaluated using a phantom. Mean lactate SNR (a)
and choline to NAA ratio (Cho/NAA) (b) were compared between the right (R), left (L), middle (M), anterior (A), and posterior (P)
voxels of the excited volume. As the over-PRESS factor increased from 1.2 to 1.7, the chemical shift artifact lessened.
PARK et al. 198over-PRESS factors and rapidly increased with
increases in the over-PRESS factor. The differences
between the lactate SNR from the left and right voxel
were 12 and 6 for the over-PRESS factors of 1.2 and
1.5, respectively, and hardly noticeable for the over-
PRESS factor of 1.7 (Fig. 4a). The Cho/NAA dis-
played a similar pattern. The Cho/NAA values from
the different regions of the excited volume converged
as the over-PRESS factor increased, whereas the mean
Cho/NAA from the ﬁve regions were similar across the
three over-PRESS factors (Table 2). Figure 5 shows
the color-maps of lactate SNR and the corresponding
lactate spectra for the three over-PRESS factors. The
spectra were taken from the central slice of the PRESS
3D volume. The color maps were generated by spa-
tially interpolating lactate SNR values to the resolu-
tion of anatomical images using a linear kernel. The
map with an 1.2 over-PRESS factor showed a large
signal drop-off in the left region of the spectra, which
was alleviated with an 1.5 over-PRESS factor. The
map with an 1.7 over-PRESS factor showed fairly
uniform signal intensity across the entire region.
The artifact caused by the spatial interference of
lactate methyl and methine spins appeared to be min-
imal. Figure 6 shows MRSI data sets zoomed-in
around lactate doublet from the BASING edit-on (ﬁrst
cycle) and edit-off (second cycle) scans with an 1.5
over-PRESS factor. The lactate doublets from the ﬁrst
and second cycles were relatively uniform throughout
the excited volume with a slight signal drop-off in the
left column. The intensity and distribution of lactate
(d) (f)  (e) 
(c)  (b)  (a) 
21 
0 
16 
11 
5 
FIGURE 5. The distribution of lactate methyl doublet from MRSI data using phantom. The top images show the color maps of
lactate SNR for the over-PRESS factors of 1.2 (a), 1.5 (b), and 1.7 (c). The corresponding spectra zoomed-in around lactate doublet
are shown in the bottom for the over-PRESS factors of 1.2 (d), 1.5 (e), and 1.7 (f). The lactate doublet in the left column (highlight)
had lower intensity compared to other regions of the PRESS volume for the over-PRESS factors of 1.2 and 1.5. The overall
uniformity of lactate intensity increased with increases in the over-PRESS factor.
TABLE 2. Comparison between three over-PRESS factors.
Over-PRESS factor
1.2 1.5 1.7
Lactate SNR 15 (4.7) 16 (2.5) 16 (1.1)
Cho/NAA 0.60 (0.14) 0.59 (0.04) 0.59 (0.02)
The mean and SD of lactate SNR and choline to NAA ratio (Cho/
NAA) across the ﬁve regions of the excited volume for different
over-PRESS factors. The numbers inside parenthesis indicate the
SD.
cycle 1  cycle 2 
FIGURE 6. Lactate spectra from the ﬁrst (edit-on) and
second (edit-off) cycles acquired from phantom using the
over-PRESS factor of 1.5. The use of higher-bandwidth 180
refocusing pulses in combination with over-prescription and
high bandwidth VSS pulses minimized signal cancellation
across the excited volume and provided relatively uniform
lactate signal for both data sets.
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ﬁrst cycle, except that they are 180 out-of-phase to
each other. It indicates that the use of higher-band-
width 180 pulses in combination with over-PRESS
and high bandwidth VSS pulses was able to minimize
the chemical shift artifact.
Comparison Between the Conventional Phase Encoding
and Flyback Readout Gradient Methods
Lactate-edited MRSI spectra acquired with a ﬂy-
back readout gradient demonstrated excellent detec-
tion of uncoupled spins in the summed spectra and
lactate in the subtracted spectra for phantoms and
volunteers. The over-PRESS and use of high
bandwidth VSS pulses provided minimal chemical shift
mis-registration. Figure 7 shows an example of spec-
troscopic voxels from the lactate-edited MRSI with a
ﬂyback echo-planar readout gradient in a phantom
(a, b) and a volunteer (c, d). In the subtracted spectra
(b, d), the lactate doublet at 1.3 ppm was observed in
the phantom data (b), but not in the healthy volunteer (d).
Cho, Cr, and NAA were summed (a, c) or removed
(b, d) for both the phantom and volunteer. The median
raw SNR of Cho, Cr, and NAA from the ﬂyback
method was 50, 60, and 84 for phantom and 10, 8, and
19 for volunteers, respectively. The median raw SNR
of lactate from the ﬂyback method was 18 for the
phantom. The median normalized SNR values of brain
metabolites and their ratios from the ﬂyback method
are compared to those from the conventional phase
encoding method for phantom and volunteers in
Table 3. The signal reduction for the ﬂyback method
compared to the conventional phase encoding ranged
from 17 to 22% in the phantom and 19 to 25% in
volunteers for Cho, Cr, NAA, and lactate (Table 3).
An example of spectra from a volunteer comparing the
two MRSI methods is shown in Fig. 8.
Patient Data from the Lactate-Edited 3D MRSI
with a Flyback Gradient
Seven patients showed the presence of lactate peaks
and lactate with a SNR greater than 4 was observed in
Lac
Cho
Cr
NAA
3.0 2.0 1.0 PPM 3.0 2.0 1.0 PPM
Cho Cr
NAA (e) PRESS (a)
(b) (d)
(c)
FIGURE 7. Lactate-edited spectra with a ﬂyback gradient in a phantom (a, b) and a volunteer (c, d). Lactate is detected in the
subtracted spectrum of phantom (b), and uncoupled resonances are produced in summed spectra in both phantom (a) and
volunteer (c). T1-weighted image from the volunteer (e) shows the PRESS box and the voxel chosen for the spectra.
TABLE 3. The median SNR values and metabolite ratios of brain metabolites for raw ﬂyback, normalized ﬂyback,
and conventional MRSI methods.
Phantom (n = 1) Volunteer (NAWM, n = 2)
Patients (NAWM,
n = 33)
rFB nFB cMRSI rFB nFB cMRSI rFB nFB
Cho 50 173 208 10 35 43 10 34
Cr 60 207 262 8 29 39 8 28
NAA 84 288 349 19 66 85 17 59
Lac 18 61 78 5
a 17
a
Cho/NAA 0.60 0.60 0.53 0.51 0.59
Lac/NAA 0.21 0.22 0.30
a
NAWM normal appearing white matter, rFB raw ﬂyback, nFB normalized ﬂyback, cMRSI conventional MRSI with elliptical k-space sampling,
Cho/NAA choline to NAA ratio, Lac/NAA lactate to NAA ratio.
aLactate in patients was measured from the contrast enhancing lesion or T2 hyperintense region and lactate in necrosis or resection cavity
was excluded.
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SNR of lactate in those patients was 17. The SNR of
Cho, Cr, and NAA in NAWM from all patients were
similar to the values in NAWM from normal volun-
teers (not signiﬁcantly diﬀerent in a Mann–Whitney
rank sum test with p>0.4) (Table 3). The Cho/NAA
in NAWM from the patients were similar to the values
from healthy volunteers (not signiﬁcantly different in a
Mann–Whitney rank sum test with p>0.3) and
comparable to the values reported in several litera-
tures.
5,32 An example of data from a patient who had
lactate in the CEL is shown in Fig. 9. Voxel (a) and (b)
were taken from the CEL in the T1-weighted post-
contrast image, and voxel (c) was taken from the nor-
mal tissue in the contra-lateral hemisphere. The voxels
in the top row are summed spectra, and the voxels in
the bottom row are subtracted spectra. High Cho levels
were observed in the summed spectrum of the voxel (a)
and (b), which is characteristic of tumor, and the
presence of lipid in the summed spectrum of the
voxel (b) may indicate necrosis. Lactate appeared in
the voxels with lesions (a, b). Lactate doublets were
(a)  (b)  (c) 
FIGURE 8. Comparison of MRSI data between the ﬂyback-gradient method (a) and the conventional elliptical MRSI method (c)
from a volunteer. T1-weighted SPGR (b) shows PRESS box and the spectral array.
Cho 
(9)  Cr 
(13) 
NAA 
(16)  Cho (12) 
Lipid (8) 
Lac (9) 
Cho (20) 
Lac (7) 
a 
b  c 
(a) (b)  (c) 
FIGURE 9. An example of lactate-edited spectra using the ﬂyback-gradient method from a patient. The voxels in contrast
enhancing lesions (a, b) contain high choline (Cho) as well as lipid in summed spectra (top) and lactate in subtracted spectra
(bottom). The normal tissue from contra-lateral hemisphere (c) shows normal display of brain metabolite level (top in c) without
lactate (bottom in c). The numbers indicate raw SNR values.
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even with the presence of lipid. The voxel in the contra-
lateral hemisphere contained normal levels of Cho, Cr,
and NAA (c) with no lactate in the corresponding
subtracted spectrum.
Another example of a patient exam that was
acquired with the lactate-edited MRSI using a ﬂyback
echo-planar readout gradient is shown in Fig. 10. This
shows the summed and subtracted spectra for the full
coverage of a slice from the PRESS volume. The T2-
weighted image from this patient (bottom in b) showed
a large area of T2h in the left hemisphere, which
consisted of a large necrotic area surrounded by a
contrast enhancing rim, as depicted in T1-weighted
post-contrast image (top in b). The summed spectra (a)
showed abnormal levels of brain metabolites with high
Cho and low NAA in the CEL and T2h. Several voxels
in the necrotic area contained lipid. In the subtracted
spectra (c), lactate doublet peaks were observed in the
lesions.
DISCUSSION
This study demonstrated the feasibility of detecting
lactate, as well as Cho, Cr, NAA, and lipid in 9.5 min
using a new 3 T lactate-edited PRESS 3D MRSI
sequence with a ﬂyback echo-planar readout gradient.
Using this approach, we were able to detect lactate in
patients with brain tumors (median normalized
SNR = 17) using a nominal voxel size of 1 cc and a
factor of two reduction in scan time compared to
conventional elliptical phase encoding MRSI (19 min).
Implementation of higher-bandwidth volume selec-
tion pulses was required because of the increased
chemical shift between lactate methyl (1.3 ppm) and
methine (4.1 ppm) resonances at higher ﬁeld. It should
be noted that the bandwidth of slice selective 180
pulses in the current study (1500 Hz) was higher than
those reported in the previous studies (ranging from
874 to 1385 Hz) which used a PRESS scheme for
volume selection at 3 T.
14,16,28 The use of higher-
bandwidth pulses was important in minimizing chem-
ical shift mis-registration because the chemical shift
artifact is inversely proportional to the size of the RF
bandwidth used for localization. The use of an
over-PRESS factor and high bandwidth VSS pulses
further minimized artifacts from chemical shift mis-
registration.
Over-PRESS factors of 1.2, 1.5, and 1.7 were tested
in this study in order to minimize the chemical shift
mis-registration of two lactate resonances as well as
other metabolites. Although the higher factor would
have given more uniform lactate signal and metabolite
ratios, an over-PRESS factor of 1.5 was used for all
volunteer and patient scans because of the proximity of
the excited volume to the subject’s skull and the
potential of having increased contamination from
subcutaneous lipid with an 1.7 over-PRESS factor.
Although, in theory, the chemical shift artifact
should be eliminated with an 1.5 over-PRESS factor
since the excited box (91 9 102 mm) is bigger than the
prescribed box (80 9 80 mm) (Fig. 3b), the lactate
spectra with an 1.5 over-PRESS factor were still not
completely uniform. Imperfections in slice selection
may have contributed to the artifact. The lactate signal
in the left column was relatively smaller than those in
the rest of the excited volume, however, the variation
of lactate level over the entire excited volume was
relatively small and showed signiﬁcant improvement
over the lactate spectra acquired with the over-PRESS
factor of 1.2 (Fig. 5). The lactate SNRs in regions
(a) (b) (c)
FIGURE 10. An example of lactate-edited spectra using the ﬂyback-gradient method from a patient, showing the full coverage of a
slice from the PRESS volume. In the summed spectra (a), the highlighted voxels show abnormal levels of metabolites with highly
elevated choline around lesions in T1 post-contrast image (top, b) and T2-weighted FLAIR image (bottom, b). The highlighted
voxels in the subtracted spectra (c) show lactate doublet at 1.3 ppm.
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PRESS factor of 1.5 with the SD of 0.5 (Fig. 4). When
interpreting lactate peaks in the left column, one
should note the possibility of underestimating lactate
in this region and may use other means to correct for
the chemical shift artifacts. This can either be achieved
using theoretical corrections that are determined from
the size of the PRESS selected volume, the over-
PRESS factor and the bandwidths of the selection
pulses or to acquire empirical data with similar
parameters from a uniform phantom and use the ratio
of lactate intensities in different voxels to provide
correction factors.
The trade-oﬀ in using a ﬂyback echo-planar readout
gradient is a decrease in sensitivity. The median signal
reduction for the ﬂyback echo-planar readout gradient
compared to the conventional phase encoding in the
normalized SNR of NAA was 17% for phantom and
22% for volunteers (Table 3), which are similar to
previous ﬁndings described by Cunningham et al.
3 The
loss of data during rewind portion of the ﬂyback tra-
jectory and imperfections in the gradient trajectory
contributed to the net signal loss. Lactate peaks with
SNR smaller than 4 were difﬁcult to be distinguished
from noise, and therefore the SNR of 4 was used as a
threshold for calculating the median SNR of lactate in
patients. Although the conventional phase encoding
method may provide higher sensitivity for lactate
detection, especially when lactate concentration in
tumors is small, the long scan time (20 min) has tra-
ditionally prevented it from being used in routine
clinical practices. By integrating the ﬂyback echo-
planar readout gradient, we have made possible a
factor of two reduction in scan time (9.5 min). As the
use of 3 T scanner becomes more widespread due to its
improved SNR associated with higher ﬁeld strength,
this technique is expected to be more appropriate for
routine clinical uses and may assist in evaluating the
role of lactate in the management of brain tumors.
In most cases, the highest lactate signal was observed
in necrosis or resection cavity with a raw SNR as high
as 18 in these regions. It is known that lactate produced
in cancerous cells can accumulate in cystic or necrotic
regions.
13 Since lactate in these regions has been
reported to be clinically irrelevant,
2 we limited our
estimation of lactate signal to CEL or T2h and
excluded lactate in necrosis and resection cavity.
The current study was primarily aimed at demon-
strating the practicability of detecting lactate signal
using the new lactate-edited 3D MRSI sequence in
patients with brain tumors at 3 T; hence the clinical
interpretation of lactate was omitted. A study assessing
the patterns of lactate prior to radiation and during
treatment in GBM patients is currently underway in an
attempt to predict treatment outcome.
CONCLUSIONS
We have developed and implemented a lactate-
edited 3D MRSI sequence that incorporates specialized
rf pulses and a ﬂyback echo-planar readout gradient at
3 T. The results from the current work demonstrated
the ability of this sequence to detect lactate in the
presence of lipid signal from brain tumor patients in a
clinically acceptable acquisition time of 9.5 min. While
further studies are required, this robust technique
should permit non-invasive measurement of brain lac-
tate as well as Cho, Cr, NAA, and lipid in routine
clinical settings at 3 T and may assist in investigating its
potential as a marker for prognosis and response to
therapy.
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